SearcharxivSearch

arXiv subjects

Rohan Iyer

Publications and source records attributed to Rohan Iyer.

11 recordsLinked to original sources

Adaptive Self-Supervised Learning Strategies for Dynamic On-Device LLM Personalization

Large language models (LLMs) have revolutionized how we interact with technology, but their personalization to individual user preferences remains a significant challenge, particularly in on-device applications. Traditional methods often depend heavily on labeled datasets and can be resource-intensive. To address these issues, we present Adaptive Self-Supervised Learning Strategies (ASLS), which utilizes self-supervised learning techniques to personalize LLMs dynamically. The framework comprises a user profiling layer for collecting interaction data and a neural adaptation layer for real-time model fine-tuning. This innovative approach enables continuous learning from user feedback, allowing the model to generate responses that align closely with user-specific contexts. The adaptive mechanisms of ASLS minimize computational demands and enhance personalization efficiency. Experimental results across various user scenarios illustrate the superior performance of ASLS in boosting user engagement and satisfaction, highlighting its potential to redefine LLMs as highly responsive and context-aware systems on-device.

cs.CL

Vaccination Worldwide: Strategies, Distribution and Challenges

The Coronavirus 2019 (Covid-19) pandemic caused by the SARS-CoV-2 virus represents an unprecedented crisis for our planet. It is a bane of the \"uber connected world that we live in that this virus has affected almost all countries and caused mortality and economic upheaval at a scale whose effects are going to be felt for generations to come. While we can all be buoyed at the pace at which vaccines have been developed and brought to market, there are still challenges ahead for all countries to get their populations vaccinated equitably and effectively. This paper provides an overview of ongoing immunization efforts in various countries. In this early draft, we have identified a few key factors that we use to review different countries' current COVID-19 immunization strategies and their strengths and draw conclusions so that policymakers worldwide can learn from them. Our paper focuses on processes related to vaccine approval, allocation and prioritization, distribution strategies, population to vaccine ratio, vaccination governance, accessibility and use of digital solutions, and government policies. The statistics and numbers are dated as per the draft date [June 24th, 2021].

q-bio.PE

Paper card-based vs application-based vaccine credentials: a comparison

In this early draft, we provide an overview on similarities and differences in the implementation of a paper card-based vaccine credential system and an app-based vaccine credential system. A vaccine credential's primary goal is to regulate entry and ensure safety of individuals within densely packed public locations and workspaces. This is critical for containing the rapid spread of Covid-19 in densely packed public locations since a single individual can infect a large majority of people in a crowd. A vaccine credential can also provide information such as an individual's Covid-19 vaccination history and adverse symptom reaction history to judge their potential impact on the overall health of individuals within densely packed public locations and workspaces. After completing the comparisons, we believe a card-based implementation will benefit regions with less socioeconomic mobility, limited resources, and stagnant administrations. An app-based implementation on the other hand will benefit regions with equitable internet access and lower technological divide. We also believe an interoperable system of both credential systems will work best for regions with enormous working-class populations and dense housing clusters.

cs.CY

MIT SafePaths Card (MiSaCa): Augmenting Paper Based Vaccination Cards with Printed Codes

In this early draft, we describe a user-centric, card-based system for vaccine distribution. Our system makes use of digitally signed QR codes and their use for phased vaccine distribution, vaccine administration/record-keeping, immunization verification, and follow-up symptom reporting. Furthermore, we propose and describe a complementary scanner app system to be used by vaccination clinics, public health officials, and immunization verification parties to effectively utilize card-based framework. We believe that the proposed system provides a privacy-preserving and efficient framework for vaccine distribution in both developed and developing regions.

cs.CY

COVID-19 Tests Gone Rogue: Privacy, Efficacy, Mismanagement and Misunderstandings

COVID-19 testing, the cornerstone for effective screening and identification of COVID-19 cases, remains paramount as an intervention tool to curb the spread of COVID-19 both at local and national levels. However, the speed at which the pandemic struck and the response was rolled out, the widespread impact on healthcare infrastructure, the lack of sufficient preparation within the public health system, and the complexity of the crisis led to utter confusion among test-takers. Invasion of privacy remains a crucial concern. The user experience of test takers remains low. User friction affects user behavior and discourages participation in testing programs. Test efficacy has been overstated. Test results are poorly understood resulting in inappropriate follow-up recommendations. Herein, we review the current landscape of COVID-19 testing, identify four key challenges, and discuss the consequences of the failure to address these challenges. The current infrastructure around testing and information propagation is highly privacy-invasive and does not leverage scalable digital components. In this work, we discuss challenges complicating the existing covid-19 testing ecosystem and highlight the need to improve the testing experience for the user and reduce privacy invasions. Digital tools will play a critical role in resolving these challenges.

cs.CY

Spatial K-anonymity: A Privacy-preserving Method for COVID-19 Related Geospatial Technologies

There is a growing need for spatial privacy considerations in the many geo-spatial technologies that have been created as solutions for COVID-19-related issues. Although effective geo-spatial technologies have already been rolled out, most have significantly sacrificed privacy for utility. In this paper, we explore spatial k-anonymity, a privacy-preserving method that can address this unnecessary tradeoff by providing the best of both privacy and utility. After evaluating its past implications in geo-spatial use cases, we propose applications of spatial k-anonymity in the data sharing and managing of COVID-19 contact tracing technologies as well as heat maps showing a user's travel history. We then justify our propositions by comparing spatial k-anonymity with several other spatial privacy methods, including differential privacy, geo-indistinguishability, and manual consent based redaction. Our hope is to raise awareness of the ever-growing risks associated with spatial privacy and how they can be solved with Spatial K-anonymity.

cs.CR

Digital Landscape of COVID-19 Testing: Challenges and Opportunities

The COVID-19 Pandemic has left a devastating trail all over the world, in terms of loss of lives, economic decline, travel restrictions, trade deficit, and collapsing economy including real-estate, job loss, loss of health benefits, the decline in quality of access to care and services and overall quality of life. Immunization from the anticipated vaccines will not be the stand-alone guideline that will help surpass the pandemic and return to normalcy. Four pillars of effective public health intervention include diagnostic testing for both asymptomatic and symptomatic individuals, contact tracing, quarantine of individuals with symptoms or who are exposed to COVID-19, and maintaining strict hygiene standards at the individual and community level. Digital technology, currently being used for COVID-19 testing include certain mobile apps, web dashboards, and online self-assessment tools. Herein, we look into various digital solutions adapted by communities across universities, businesses, and other organizations. We summarize the challenges experienced using these tools in terms of quality of information, privacy, and user-centric issues. Despite numerous digital solutions available and being developed, many vary in terms of information being shared in terms of both quality and quantity, which can be overwhelming to the users. Understanding the testing landscape through a digital lens will give a clear insight into the multiple challenges that we face including data privacy, cost, and miscommunication. It is the destiny of digitalization to navigate testing for COVID-19. Block-chain based systems can be used for privacy preservation and ensuring ownership of the data to remain with the user. Another solution involves having digital health passports with relevant and correct information. In this early draft, we summarize the challenges and propose possible solutions to address the same.

cs.CY

Challenges of Equitable Vaccine Distribution in the COVID-19 Pandemic

The COVID-19 pandemic has led to a need for widespread and rapid vaccine development. As several vaccines have recently been approved for human use or are in different stages of development, governments across the world are preparing comprehensive guidelines for vaccine distribution and monitoring. In this early article, we identify challenges in logistics, health outcomes, user-centric matters, and communication associated with disease-related, individual, societal, economic, and privacy consequences. Primary challenges include difficulty in equitable distribution, vaccine efficacy, duration of immunity, multi-dose adherence, and privacy-focused record-keeping to be HIPAA compliant. While many of these challenges have been previously identified and addressed, some have not been acknowledged from a comprehensive view accounting for unprecedented interactions between challenges and specific populations. The logistics of equitable widespread vaccine distribution in disparate populations and countries of various economic, racial, and cultural constitutions must be thoroughly examined and accounted for. We also describe unique challenges regarding the efficacy of vaccines in specialized populations including children, the elderly, and immunocompromised individuals. Furthermore, we report the potential for understudied drug-vaccine interactions as well as the possibility that certain vaccine platforms may increase susceptibility to HIV. Given these complicated issues, the importance of privacy-focused, user-centric systems for vaccine education and incentivization along with clear communication from governments, organizations, and academic institutions is imperative. These challenges are by no means insurmountable, but require careful attention to avoid consequences spanning a range of disease-related, individual, societal, economic, and security domains.

econ.GN

Clinical Landscape of COVID-19 Testing: Difficult Choices

The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the world, leading to enormous amounts of human death and economic loss. Until definitive preventive or curative measures are developed, policies regarding testing, contact tracing, and quarantine remain the best public health tools for curbing viral spread. Testing is a crucial component of these efforts, enabling the identification and isolation of infected individuals. Differences in testing methodologies, time frames, and outcomes can have an impact on their overall efficiency, usability and efficacy. In this early draft, we draw a comparison between the various types of diagnostic tests including PCR, antigen, and home tests in relation to their relative advantages, disadvantages, and use cases. We also look into alternative and unconventional methods. Further, we analyze the short-term and long-term impacts of the virus and its testing on various verticals such as business, government laws, policies, and healthcare.

q-bio.OT

Target Privacy Threat Modeling for COVID-19 Exposure Notification Systems

The adoption of digital contact tracing (DCT) technology during the COVID-19pandemic has shown multiple benefits, including helping to slow the spread of infectious disease and to improve the dissemination of accurate information. However, to support both ethical technology deployment and user adoption, privacy must be at the forefront. With the loss of privacy being a critical threat, thorough threat modeling will help us to strategize and protect privacy as digital contact tracing technologies advance. Various threat modeling frameworks exist today, such as LINDDUN, STRIDE, PASTA, and NIST, which focus on software system privacy, system security, application security, and data-centric risk, respectively. When applied to the exposure notification system (ENS) context, these models provide a thorough view of the software side but fall short in addressing the integrated nature of hardware, humans, regulations, and software involved in such systems. Our approach addresses ENSsas a whole and provides a model that addresses the privacy complexities of a multi-faceted solution. We define privacy principles, privacy threats, attacker capabilities, and a comprehensive threat model. Finally, we outline threat mitigation strategies that address the various threats defined in our model

cs.CR

Comparing manual contact tracing and digital contact advice

Manual contact tracing is a top-down solution that starts with contact tracers at the public health level, who identify the contacts of infected individuals, interview them to get additional context about the exposure, and also monitor their symptoms and support them until the incubation period is passed. On the other hand, digital contact tracing is a bottom-up solution that starts with citizens who on obtaining a notification about possible exposure to an infected individual may choose to ignore the notification, get tested to determine if they were actually exposed or self-isolate and monitor their symptoms over the next two weeks. Most experts recommend a combination of manual contact tracing and digital contact advice but they are not based on a scientific basis. For example, a possible hybrid solution could involve a smartphone based alert that requests the possible contact of an infected individual to call the Public Health (PH) number for next steps, or in some cases, suggest ways to self-assess in order to reduce the burden on PH so only most critical cases require a phone conversation. In this paper, we aim to compare the manual and digital approaches to contact tracing and provide suggestions for potential hybrid solutions.

cs.CY